Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focus

seekingalpha.com · 2026-11-01

Healthcare stocks outperformed as tech sold off. See top healthcare winners, earnings beats, M&A news, and key pharma updates driving the sector now.

TickrTrends take: AstraZeneca appears in this week's notable healthcare headlines alongside major competitors Eli Lilly and Merck, suggesting active developments in the sector that investors should monitor for potential valuation implications. Given TickrTrends' current undervalued assessment for AZN, any news regarding pipeline progress, regulatory decisions, or competitive positioning among these three companies could influence whether the current valuation discount persists. Healthcare investors tracking AZN should pay particular attention to how AstraZeneca's news flow this week compares to its larger competitors' announcements in terms of clinical or commercial significance.

Read the full story at seekingalpha.com →